JENNIFER FALTER: Open Payments
NPI 1972267359 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,257 in 140 payments from 17 companies in 2025. Trend: 2023 $2,514 · 2024 $2,769 · 2025 $3,257
Food & beverage: $2,885Education: $372
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $466 |
| PFIZER INC. | 26 | $444 |
| GENZYME CORPORATION | 15 | $408 |
| Regeneron Healthcare Solutions, Inc. | 13 | $350 |
| Galderma Laboratories, L.P. | 17 | $273 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $261 |
| ABBVIE INC. | 16 | $252 |
| UCB, Inc. | 9 | $247 |
| E.R. Squibb & Sons, L.L.C. | 7 | $207 |
| Lilly USA, LLC | 8 | $117 |
Products named: DUPIXENT, TREMFYA, CIBINQO, NEMLUVIO, RINVOQ, Bimzelx, Sotyktu, Winlevi.
Industry payments across OK — which companies pay providers there.
